Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation SequencingBusiness Wire • 08/20/26
International Markets and Charles River (CRL): A Deep Dive for InvestorsZacks Investment Research • 08/10/26
Charles River Laboratories International, Inc. (CRL) Q2 2026 Earnings Call TranscriptSeeking Alpha • 08/05/26
CRL Q2 Earnings and Revenues Top, '26 View Up, Stock Up in Pre-MarketZacks Investment Research • 08/05/26
Has Charles River Laboratories International (CRL) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 08/05/26
Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 08/05/26
Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass EstimatesZacks Investment Research • 08/05/26
Charles River Blows Out Of A Buy Zone After One Metric Hits A Four-Year HighInvestors Business Daily • 08/05/26
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/29/26
What Makes Charles River Laboratories (CRL) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 07/17/26
Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference CallBusiness Wire • 07/15/26
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 07/14/26
Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment ApproachesBusiness Wire • 07/13/26
Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PRNewsWire • 07/03/26
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?The Motley Fool • 06/22/26